BioCentury
ARTICLE | Politics & Policy

BIO requests review of double-patent ruling

October 16, 2000 7:00 AM UTC

The Biotechnology Industry Organization ( S*BIO) announced Monday that it has requested that a federal court reconsider the legal logic it used to decide a patent dispute among several of the organization's members.

S*BIO submitted a friend of the court brief supporting Eli Lilly's request for the U.S. Court of Appeals for the Federal Circuit to clarify a ruling in a case the company brought against companies that are attempting to market a generic version of Prozac. The appellants include Barr Laboratories, Geneva Pharmaceuticals, Apotex and Interpharm. LLY, Apotex and Interpharm are S*BIO members. ...